Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

April 12, 2024

Conditions
Verruca Plantaris
Interventions
OTHER

Sterile water foot bath

Participants will use the same foot bath and sterile water used in the treatment arm minus the active ingredients.

DRUG

Nitric Oxide

Participants will use a foot bath filled with 500mL of NORS for 15 min. The solution's two components are mixed 1:1 to 500mL in the foot bath immediately before treatment. The solution contains NO at 68.9ppm\*hrs and 203.2ppm\*hrs for 1X and 2X solutions respectively, and it acts as a virucidal agent. Instructions for storage, handling, and use will be provided to site staff and participants.

Trial Locations (3)

V3R 1J7

Achilles Foot Health Centre, Surrey

V5Z 2T1

Spectrum Health, Vancouver

V6H 4E1

Pacific Derm, Vancouver

All Listed Sponsors
lead

Sanotize Research and Development corp.

INDUSTRY